When: Close below $207 on meaningful volume

Then: Exit all long exposure non-negotiable

When: Confirmed close above $220.78 on volume ≥130M reclaiming all three resistance layers

Then: Review for potential upgrade to Overweight

When: Close at $195.68 on meaningful volume (200 SMA structural break)

Then: Full thesis review toward Underweight

HOLD with tighter entry discipline and possible partial trim into strength

• Re-entry range of 208.61 to 208.80 is a contingent plan, not a commitment
• 10-year yield at highest since January 2025; Polymarket pricing less than 10% odds of December cut
• Oil above 90 on active Iran strikes; IBD naming NVDA as same-day decliner on macro factors
• Every 25 basis points yield rise historically pressures NVDA 3-5%
• NVDA beta of 2.2 means a 10% market decline translates to over 20% on this name
• Q1 FY27: 81.6 billion revenue, 65.6% operating margin, 117% ROE
• Trailing PEG of 0.63 is a lagging indicator; analyst estimates get revised down in tough macro regimes
• Forward EPS estimate: 15.40
• Equity investment gains of 15.9 billion in Q1 flatter reported earnings vs. underlying operating reality
• Top four hyperscalers likely over 40% of revenue concentration risk
• Custom silicon threat from Google TPU, Amazon Trainium, Microsoft Maia
• Inventory build has more than doubled year-over-year
• WallStreetBets near peak euphoria (Jensen emoji, $25K expiring Friday brag, Burry reference) as leading indicator of fragility
• Aug 27 blowoff on 2x volume followed by declining volume bounces precedes larger distribution leg
• AI capex survival bias: capex gets cut first in recessions (2008-2009 precedent)
• Initial tranche should be quarter allocation not half given macro headwind and 2.2 beta
• Second tranche requires macro cooperation: if 10y still rising or oil still above 90, skip the add regardless of price signal

→ vs aggressive: Macro dismissal is dangerous; 10y at highest since Jan 2025, <10% Dec cut odds, oil above 90, IBD flagging NVDA as same-day decliner on macro factors

→ vs aggressive: 9:1 reward-to-risk is meaningless if stop hits 6/10 times before target materializes; probability of stop hitting is meaningfully higher than admitted

→ vs aggressive: AI capex will continue regardless of rates is survivorship bias; 2008-2009 precedent shows capex gets cut first

→ vs aggressive: Underweighting beta: 2.2 beta amplifies every macro drawdown; 10% market decline = 22% on NVDA

→ vs aggressive: Retail crowding signal (WSB euphoria) is leading indicator of fragility, not confirmation

→ vs aggressive: Trailing PEG of 0.63 misread as forward guarantee; PEG is lagging indicator built on estimates that get revised down in tough macro

→ vs neutral: Even more caveats than neutral's likely plan are warranted; would add concentration risk trim given 40%+ hyperscaler revenue, custom silicon threat, and doubled inventory

→ vs neutral: Fundamentals are real but largely in the price; next leg requires EPS beat above 15.40 or multiple re-expansion, both requiring macro cooperation

HOLD with refined entry: 33-40% tranche at 208.61-208.80, macro gates on 10-year/oil, put protection hedging (1-2% cost, 30-60 day puts near 207 strike), potential allocation to lower-beta AI ecosystem names

• Agrees fundamentals exceptional: Q1 FY27 81.6 billion revenue, 65.6 percent operating margins, PEG of 0.63
• Agrees 208.61-208.80 zone is valid technical confluence with 207 defined stop
• Disagrees macro is noise: 10-year at highest since January 2025, Polymarket pricing zero probability of December cut, oil above 90 on Iran strikes
• Beta of 2.2 amplifies drawdowns; rising cost of capital creates board-level capex vs. capital return tradeoffs
• Agrees Aug 27 blowoff on roughly 2x normal volume followed by declining volume bounces is textbook distribution pattern
• Agrees WSB euphoria at near peak (Jensen emoji posts, options printing brags) historically precedes fragility
• Agrees 15.9 billion other income flatters reported earnings
• Agrees 25.8 billion inventory build has more than doubled year-over-year and needs conversion without margin reset
• Disagrees trimming is premature: fundamentals accelerating, forward EPS expected to nearly double
• Anthropic Lambda MediaTek AWS deal flow is multi-quarter visibility story extending cash flow runway beyond trailing numbers
• Suggests split allocation: around 33-40% initial tranche (between aggressive's 50% and conservative's 25%)
• Suggests explicit macro gate: if 10-year still rising or oil still above 90 at entry zone, defer by defined sessions or scale down further
• Suggests put protection as portfolio insurance rather than trimming: 1-2% of position value for 30-60 day protective puts struck near or just below 207
• Suggests evaluating alternative AI capex exposure (Micron on HBM, neoclouds like Nebius/CoreWeave) for correlated upside with lower single-name beta
• NVDA at 5.25 trillion dollar market cap with 2.2 beta presents concentration risk relative to smaller ecosystem players

→ vs aggressive: Macro dismissal is refusal to update, not conviction; 10-year at cycle highs, zero December cut probability, oil above 90, and IBD naming NVDA as same-day decliner on those factors is active headwind, not noise

→ vs conservative: Trimming is premature when fundamentals are accelerating and earnings engine is doing heavy lifting; selling into structural uptrend with hostile macro that has already pulled prices lower is historically when you should be adding, not subtracting